396 related articles for article (PubMed ID: 2307845)
1. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
2. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
5. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
Gyetko MR; Shollenberger SB; Sitrin RG
J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
[TBL] [Abstract][Full Text] [Related]
6. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
9. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
Tanabe T
Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
[TBL] [Abstract][Full Text] [Related]
10. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
12. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
13. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity.
Manchanda N; Schwartz BS
J Immunol; 1990 Dec; 145(12):4174-80. PubMed ID: 2258614
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
17. The plasminogen-activating system in hepatic stellate cells.
Leyland H; Gentry J; Arthur MJ; Benyon RC
Hepatology; 1996 Nov; 24(5):1172-8. PubMed ID: 8903394
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
19. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of plasminogen activator and inhibitor in the lymphatic endothelium.
Leak LV; Saunders M; Day AA; Jones M
Microvasc Res; 2000 Nov; 60(3):201-11. PubMed ID: 11078636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]